[BDRX] YoY Quarter Result on 31-Mar-2022 [#Q1]

Stock
[BDRX] Biodexa Pharmaceuticals Plc
Announcement Date
30-Mar-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -32.78%
YoY- 2.92%
Quarter Report
BDRX's Result
BDRX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 0 149 234 201 84 226 275 -
PBT -1,717 -1,928 -1,699 -1,695 -8,930 -2,626 -3,255 -10.10%
Tax 63 144 169 118 220 416 445 -27.78%
NP -1,654 -1,784 -1,531 -1,577 -8,710 -2,210 -2,810 -8.44%
Tax Rate - - - - - - - -
Total Cost 1,654 1,933 1,765 1,778 8,794 2,436 3,085 -9.85%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 0.00 -1,197.32 -654.06 -786.53 -10,369.05 -977.65 -1,023.68 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -5.04 -7.19 -124.33 0.00 0.00 0.00 0.00 -
EPS Diluted -5.04 -7.19 -124.33 0.00 0.00 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.